X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs NATCO PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS NATCO PHARMA J.B.CHEMICALS/
NATCO PHARMA
 
P/E (TTM) x 17.3 13.4 129.4% View Chart
P/BV x 2.2 2.8 78.3% View Chart
Dividend Yield % 0.5 1.6 33.7%  

Financials

 J.B.CHEMICALS   NATCO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
NATCO PHARMA
Mar-18
J.B.CHEMICALS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs3631,080 33.6%   
Low Rs255671 38.0%   
Sales per share (Unadj.) Rs169.1592.1 28.6%  
Earnings per share (Unadj.) Rs16.6188.4 8.8%  
Cash flow per share (Unadj.) Rs23.4206.3 11.3%  
Dividends per share (Unadj.) Rs2.008.25 24.2%  
Dividend yield (eoy) %0.60.9 68.7%  
Book value per share (Unadj.) Rs172.5833.6 20.7%  
Shares outstanding (eoy) m83.5736.90 226.5%   
Bonus/Rights/Conversions BBIS-  
Price / Sales ratio x1.81.5 123.5%   
Avg P/E ratio x18.64.6 400.6%  
P/CF ratio (eoy) x13.24.2 311.0%  
Price / Book Value ratio x1.81.1 170.6%  
Dividend payout %12.04.4 275.2%   
Avg Mkt Cap Rs m25,82732,311 79.9%   
No. of employees `0003.84.8 78.1%   
Total wages/salary Rs m2,5113,256 77.1%   
Avg. sales/employee Rs Th3,747.44,522.5 82.9%   
Avg. wages/employee Rs Th665.7674.0 98.8%   
Avg. net profit/employee Rs Th367.81,439.0 25.6%   
INCOME DATA
Net Sales Rs m14,13521,848 64.7%  
Other income Rs m366404 90.5%   
Total revenues Rs m14,50122,252 65.2%   
Gross profit Rs m2,1789,284 23.5%  
Depreciation Rs m570662 86.1%   
Interest Rs m35154 22.7%   
Profit before tax Rs m1,9408,872 21.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5521,920 28.8%   
Profit after tax Rs m1,3876,952 20.0%  
Gross profit margin %15.442.5 36.3%  
Effective tax rate %28.521.6 131.6%   
Net profit margin %9.831.8 30.8%  
BALANCE SHEET DATA
Current assets Rs m10,47021,307 49.1%   
Current liabilities Rs m2,7495,920 46.4%   
Net working cap to sales %54.670.4 77.6%  
Current ratio x3.83.6 105.8%  
Inventory Days Days5573 75.4%  
Debtors Days Days78107 72.9%  
Net fixed assets Rs m5,81114,986 38.8%   
Share capital Rs m167369 45.3%   
"Free" reserves Rs m14,24830,353 46.9%   
Net worth Rs m14,41630,760 46.9%   
Long term debt Rs m00-   
Total assets Rs m17,64937,151 47.5%  
Interest coverage x56.658.6 96.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 136.2%   
Return on assets %8.119.1 42.1%  
Return on equity %9.622.6 42.6%  
Return on capital %13.729.3 46.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16410,322 59.7%   
Fx outflow Rs m1,3342,978 44.8%   
Net fx Rs m4,8297,343 65.8%   
CASH FLOW
From Operations Rs m1,2314,636 26.5%  
From Investments Rs m-208-11,155 1.9%  
From Financial Activity Rs m-5956,509 -9.1%  
Net Cashflow Rs m427-18 -2,372.8%  

Share Holding

Indian Promoters % 55.4 52.0 106.5%  
Foreign collaborators % 0.3 1.5 20.4%  
Indian inst/Mut Fund % 3.4 7.8 43.2%  
FIIs % 3.9 16.6 23.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 26.0 142.3%  
Shareholders   30,437 25,395 119.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   PLETHICO PHARMA  BIOCON   FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Wipro's Q1FY20 Result, Crude Oil Prices, and Top Cues in Focus Today(Pre-Open)

On Wednesday, share markets in India traded on a positive note most of the day and ended marginally higher.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 17, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - WOCKHARDT COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS